Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.1B | -960M | 10.6B | 5.1B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 1.8B | -4.9B | 1.7B | -2M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 111M | 91M | 98M | 101M |
| Other income expense | — | — | — | — |
| Pretax income | 1.1B | 1.4B | 1.0B | 1.3B |
| Tax provision | 157M | 208M | 131M | 229M |
| Net income | 921M | 1.2B | 890M | 1.1B |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.1B | 1.4B | 1.0B | 1.3B |
| Minority interests | -29M | -31M | 1M | -47M |
| Preferred stock dividends | — | — | — | — |